2-(4-methoxy-3-methylphenyl)ethylamine hydrochloride | 91251-69-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(4-methoxy-3-methylphenyl)ethylamine hydrochloride
• 英文别名: 4-methoxy-3-methyl-phenethylamine; hydrochloride；4-Methoxy-3-methyl-phenaethylamin; Hydrochlorid；3-methyl-4-methoxyphenethylamine hydrochloride；2-(4-Methoxy-3-methyl-phenyl)-ethylamine Hydrochloride；2-(4-methoxy-3-methylphenyl)ethanamine;hydrochloride
• CAS: 91251-69-3
• 化学式: C₁₀H₁₅NO*ClH
• 分子量: 201.696
• InChiKey: ZLZOYOWEVSLOCA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.93
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  35.2
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N'-(2-cyano-3,6-difluorophenyl)-N,N-dimethylformamidine 、 2-(4-methoxy-3-methylphenyl)ethylamine hydrochloride 在 溶剂黄146 作用下， 以 乙醇 为溶剂， 反应 16.0h， 以58%的产率得到(5,8-difluoroquinazolin-4-yl)[2-(4-methoxy-3-methylphenyl)ethyl]amine
  参考文献：
  名称：

  [EN] 5,8-DIFLUORO-4-(2-(4-(HETEROARYLOXY)-PHENYL)ETHYLAMINO)QUINAZOLINES AND THEIR USE AS AGROCHEMICALS
  [FR] 5,8-DIFLUORO-4-(2-(4-(HÉTÉROARYLOXY)-PHÉNYLE) ÉTHYLAMINO) QUINAZOLINES ET LEUR UTILISATION EN TANT QUE PRODUITS AGROCHIMIQUES

  摘要：

  公开号：

  WO2010025451A3

文献信息

• Therapeutic agents
  申请人：Knoll Aktiengesellschaft

  公开号：US05804586A1

  公开（公告）日：1998-09-08

  Tetrahydroisoquinoline compounds of formula I ##STR1## and pharmaceutically acceptable salts thereof, in which: R.sub.1 represents one or more substituents selected from H, halo, hydroxy, alkyl (optionally substituted by hydroxy), alkoxy, alkylthio, alkylsulphinyl, alkyl-sulphonyl, nitro, cyano, polyhaloalkyl, polyhaloalkoxy, phenyl (optionally substituted by one or more of halo, alkyl or alkoxy), or R.sub.1 is optionally alkylated carbamoyl; R.sub.2 represents a saturated or unsaturated aliphatic group optionally substituted by hydroxy or alkoxy; E represents an alkylene chain optionally substituted by one or more alkyl groups; and G represents (a) optionally substituted saturated or unsaturated alicyclic group containing 3 to 8 carbon atoms, or (b) optionally substituted saturated or unsaturated aliphatic chain containing 1 to 12 carbon atoms, or (c) optionally substituted 5 or 6 membered heterocyclic ring containing one or more N or O atoms or SO.sub.n groups in which n is 0, 1 or 2; and O-acylated derivatives thereof which provide lipophilic esters have utility in analgesia or in the treatment of psychoses (e.g. schizophrenia), Parkinson's disease, Lesch-Nyan syndrome, attention deficit disorder or cognitive impairment or in the relief of drug dependence or tardive dyskinesia.

  Tetrahydroisoquinoline化合物的化学式I ##STR1## 及其药用可接受的盐，其中：R.sub.1代表H、卤素、羟基、烷基（可选择地被羟基取代）、烷氧基、烷基硫醚、烷基磺醇、烷基磺酰基、硝基、氰基、多卤代烷基、多卤代烷氧基、苯基（可选择地被一个或多个卤素、烷基或烷氧基取代），或R.sub.1可选择地被烷基化的氨基甲酰基；R.sub.2代表饱和或不饱和的烷基基团，可选择地被羟基或烷氧基取代；E代表一个烷基链，可选择地被一个或多个烷基基团取代；G代表（a）可选择地被取代的饱和或不饱和脂环基团，含有3至8个碳原子，或（b）可选择地被取代的饱和或不饱和脂肪链，含有1至12个碳原子，或（c）可选择地被取代的含有一个或多个N或O原子或SO.sub.n基团（其中n为0、1或2）的5或6元杂环环，以及提供亲脂性酯的O-酰化衍生物，在镇痛或治疗精神病（如精神分裂症）、帕金森病、莱施-尼恩综合征、注意力缺陷障碍或认知障碍或在缓解药物依赖或迟发性运动障碍方面具有用途。
• PTERIDINES AND THEIR USE AS AGROCHEMICALS
  申请人：Brewster William K.

  公开号：US20110054173A1

  公开（公告）日：2011-03-03

  The present disclosure relates to 1- or 2-(4-(aryloxy)-phenyl)ethylamino-, oxy- or sulfanyl)pteridines and 1- or 2-(4-(heteroaryloxy)-phenyl)ethylamino-, oxy- or sulfanyl)pteridines and their use as agrochemicals and animal health products.

  本公开涉及1-或2-(4-(芳氧基)苯基)乙基氨基、氧基或硫基)喹啉和1-或2-(4-(杂芳氧基)苯基)乙基氨基、氧基或硫基)喹啉及其作为农药和动物健康产品的用途。
• [EN] PTERIDINES AND THEIR USE AS AGROCHEMICALS<br/>[FR] PTÉRIDINES ET LEUR UTILISATION COMME PRODUITS AGROCHIMIQUES
  申请人：DOW AGROSCIENCES LLC

  公开号：WO2011025505A1

  公开（公告）日：2011-03-03

  The present disclosure relates to 1- or 2-(4-(aryloxy)-phenyl)ethylamino-, oxy- or sulfanyl)pteridines and 1- or 2-(4-(heteroaryloxy)-phenyl)ethylamino-, oxy- or sulfanyl)pteridines and their use as agrochemicals and animal health products.

  本公开涉及1-或2-(4-(芳氧基)苯基)乙基氨基、氧基或硫基)喹啉和1-或2-(4-(杂芳氧基)苯基)乙基氨基、氧基或硫基)喹啉及其作为农药和动物保健产品的用途。
• Isoquinoline derivatives as therapeutic agents
  申请人：Knoll Aktiengesellschaft

  公开号：US05807868A1

  公开（公告）日：1998-09-15

  Tetrahydroisoquinoline compounds of formula I ##STR1## and pharmaceutically acceptable salts thereof, in which: R.sub.1 represents one or more substituents selected from H, halo, hydroxy, alkyl (optionally substituted by hydroxy), alkoxy, alkylthio, alkylsulphinyl, alkyl-sulphonyl, nitro, cyano, polyhaloalkyl, polyhaloalkoxy, phenyl (optionally substituted by one or more of halo, alkyl or alkoxy), or R.sub.1 is optionally alkylated carbamoyl; R.sub.2 represents a saturated or unsaturated aliphatic group optionally substituted by hydroxy or alkoxy; E represents an alkylene chain optionally substituted by one or more alkyl groups; and G represents (a) optionally substituted saturated or unsaturated alicyclic group containing 3 to 8 carbon atoms, or (b) optionally substituted saturated or unsaturated aliphatic chain containing 1 to 12 carbon atoms, or (c) optionally substituted 5 or 6 membered heterocyclic ring containing one or more N or O atoms or SO.sub.n groups in which n is 0, 1 or 2; and O-acylated derivatives thereof which provide lipophilic esters have utility in analgesia or in the treatment of psychoses (e.g. schizophrenia), Parkinson's disease, Lesch-Nyan syndrome, attention deficit disorder or cognitive impairment or in the relief of drug dependence or tardive dyskinesia.

  公式I的四氢异喹啉化合物及其药学上可接受的盐，其中：R.sub.1代表一个或多个取代基，包括H，卤素，羟基，烷基（可选地被羟基取代），烷氧基，烷基硫基，烷基亚磺酰基，烷基磺酰基，硝基，氰基，多卤代烷基，多卤代烷氧基，苯基（可选地被一个或多个卤素，烷基或烷氧基取代），或R.sub.1可选择烷基化的氨基甲酰基；R.sub.2代表一个饱和或不饱和的脂肪族基团，可选地被羟基或烷氧基取代；E代表一个烷基链，可选地被一个或多个烷基取代；G代表（a）可选地取代的饱和或不饱和的脂环族基团，其中含有3至8个碳原子，或（b）可选地取代的饱和或不饱和的脂肪链，其中含有1至12个碳原子，或（c）可选地取代的5或6元杂环环，其中含有一个或多个N或O原子或SO.sub.n基团，其中n为0、1或2；以及提供亲脂性酯的O-酰化衍生物在镇痛或治疗精神病（例如精神分裂症）、帕金森病、Lesch-Nyan综合征、注意力缺陷障碍或认知障碍或缓解药物依赖或迟发性运动障碍方面具有用途。
• 5,8-DIFLUORO-4-(2-(4-(HETEROARYLOXY)-PHENYL)ETHYLAMINO)QUINAZOLINES AND THEIR USE AS AGROCHEMICALS
  申请人：Brewster William K.

  公开号：US20100056374A1

  公开（公告）日：2010-03-04

  The present disclosure relates to 5,8-difluoro-4-(2-(4-(heteroaryloxy)-phenyl)ethylamino)quinazolines and their use as agrochemicals and animal health products.

  本公开涉及5,8-二氟-4-(2-(4-(杂环氧基)苯基)乙基氨基)喹唑啉及其作为农药和动物保健产品的用途。